Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas.
Righi L, Righi A, Vatrano S, Rapa I, Listì A, Metovic J, Rocca M, Salone M, Giovenali P, Sidoni A, Tabbò F, Dei Tos AP, Volante M, Papotti M. Righi L, et al. Among authors: listi a. Virchows Arch. 2021 Jun;478(6):1125-1134. doi: 10.1007/s00428-020-02990-7. Epub 2021 Jan 9. Virchows Arch. 2021. PMID: 33420836
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design.
Passiglia F, Bironzo P, Righi L, Listì A, Arizio F, Novello S, Volante M, Scagliotti GV. Passiglia F, et al. Among authors: listi a. Clin Lung Cancer. 2021 Jan;22(1):e63-e66. doi: 10.1016/j.cllc.2020.07.014. Epub 2020 Aug 5. Clin Lung Cancer. 2021. PMID: 32917522
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.
Malapelle U, Passiglia F, Cremolini C, Reale ML, Pepe F, Pisapia P, Avallone A, Cortinovis D, De Stefano A, Fassan M, Fontanini G, Galetta D, Lauricella C, Listì A, Loupakis F, Pagni F, Pietrantonio F, Pilotto S, Righi L, Bianchi AS, Parra HS, Tiseo M, Verzè M, Troncone G, Novello S. Malapelle U, et al. Among authors: listi a. Eur J Cancer. 2021 Mar;146:74-83. doi: 10.1016/j.ejca.2021.01.015. Epub 2021 Feb 12. Eur J Cancer. 2021. PMID: 33588147 Review.
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.
Malapelle U, Pilotto S, Passiglia F, Pepe F, Pisapia P, Righi L, Listì A, Bironzo P, Belluomini L, Tabbò F, Reale ML, Russo G, De Luca C, Novello S, Troncone G. Malapelle U, et al. Among authors: listi a. Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17. Crit Rev Oncol Hematol. 2021. PMID: 33744362 Review.
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations.
Bironzo P, Reale ML, Sperone T, Tabbò F, Caglio A, Listì A, Passiglia F, Di Maio M, Righi L, Bussolino F, Scagliotti GV, Novello S. Bironzo P, et al. Among authors: listi a. Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425. Cancers (Basel). 2021. PMID: 34067823 Free PMC article.
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.].
Esposito I, Calabria S, Piccinni C, Addesi A, Dondi L, Ronconi G, Pedrini A, Maggioni AP, Curigliano G, Listi A, Righi L, Novello S, Buglioni S, Ciliberto G, Pruneri G, Martini N. Esposito I, et al. Among authors: listi a. Recenti Prog Med. 2021 Jun;112(6):419-437. doi: 10.1701/3620.36025. Recenti Prog Med. 2021. PMID: 34128934 Italian.
Repositioning PARP inhibitors in the treatment of thoracic malignancies.
Passiglia F, Reale ML, Cetoretta V, Parlagreco E, Jacobs F, Listì A, Righi L, Bironzo P, Novello S, Scagliotti GV. Passiglia F, et al. Among authors: listi a. Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7. Cancer Treat Rev. 2021. PMID: 34261032 Review.
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center.
Luca C, Pepe F, Pisapia P, Iaccarino A, Righi L, Listì A, Russo G, Campione S, Pagni F, Nacchio M, Conticelli F, Russo M, Fabozzi T, Vigliar E, Bellevicine C, Rocco D, Laudati S, Iannaci G, Daniele B, Gridelli C, Cortinovis DL, Novello S, Molina-Vila MA, Rosell R, Troncone G, Malapelle U. Luca C, et al. Among authors: listi a. Per Med. 2022 Sep;19(5):395-401. doi: 10.2217/pme-2022-0020. Epub 2022 Jul 8. Per Med. 2022. PMID: 35801400
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
Mariniello A, Tabbò F, Indellicati D, Tesauro M, Rezmives NA, Reale ML, Listì A, Capelletto E, Carnio S, Bertaglia V, Mecca C, Consito L, De Filippis M, Bungaro M, Paratore C, Di Maio M, Passiglia F, Righi L, Sangiolo D, Novello S, Geuna M, Bironzo P. Mariniello A, et al. Among authors: listi a. Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226. Cells. 2022. PMID: 36291098 Free PMC article.
43 results